A.M.E. Claessen
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 13
- Immunotherapy and Immune Responses 9
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 6
- Physiology 11
- Sarcoidosis and Beryllium Toxicity Research 9
- Co-authors
- Jan C. Grutters (11 shared papers)Rik J. Scheper (9 shared papers)Adriane D.M. Vorselaars (5 shared papers)Coline H.M. van Moorsel (6 shared papers)Herbert M. Pinedo (3 shared papers)Chris J.L.M. Meijer (3 shared papers)Jan B. Vermorken (4 shared papers)Sybren L. Meijer (4 shared papers)
- Journals
- Clinical & Experimental Immunology (4 papers)Journal of Controlled Release (2 papers)International Journal of Cancer (2 papers)Journal of Surgical Oncology (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- NetherlandsBelgiumGermany
In The Last Decade
A.M.E. Claessen
37 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 92
- Immunology 548
- Oncology 362
- Physiology 295
- Pulmonary and Respiratory Medicine 226
- Pathology and Forensic Medicine 79
Countries citing papers authored by A.M.E. Claessen
This map shows the geographic impact of A.M.E. Claessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M.E. Claessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M.E. Claessen more than expected).
Fields of papers citing papers by A.M.E. Claessen
This network shows the impact of papers produced by A.M.E. Claessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M.E. Claessen. The network helps show where A.M.E. Claessen may publish in the future.
Co-authors
The 25 scholars most cited alongside A.M.E. Claessen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 381 | |
| 2 | 2015 | 109 | |
| 3 | 2014 | 82 | |
| 4 | 2011 | 72 | |
| 5 | 2007 | 71 | |
| 6 | 2002 | 56 | |
| 7 | 2013 | 51 | |
| 8 | 2000 | 49 | |
| 9 | 2012 | 41 | |
| 10 | Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma. | 1989 | 40 |
| 11 | 2008 | 38 | |
| 12 | 1988 | 35 | |
| 13 | Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients. | 1997 | 35 |
| 14 | 2009 | 32 | |
| 15 | 1991 | 28 | |
| 16 | 2009 | 25 | |
| 17 | 2016 | 23 | |
| 18 | 2002 | 21 | |
| 19 | 2007 | 21 | |
| 20 | 2007 | 18 |
About A.M.E. Claessen
A.M.E. Claessen is a scholar working on Immunology, Physiology, Oncology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 37 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers), Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Drug-Induced Adverse Reactions (5 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Immunology (548 citations), Oncology (362 citations), Physiology (295 citations), Pulmonary and Respiratory Medicine (226 citations) and Pathology and Forensic Medicine (79 citations). A.M.E. Claessen has collaborated with scholars based in Netherlands, Belgium and Germany. Frequent co-authors include Jan C. Grutters, Rik J. Scheper, Adriane D.M. Vorselaars, Coline H.M. van Moorsel, Herbert M. Pinedo, Chris J.L.M. Meijer, Jan B. Vermorken, Sybren L. Meijer, Elisabeth Bloemena and Heleen van Velzen‐Blad. Their work appears in journals such as Clinical & Experimental Immunology, Journal of Controlled Release, International Journal of Cancer, Journal of Surgical Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.